Aceso Life Science Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is April - March.

Millions HKD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jan '26 Jan 20, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	886	369	1,174	1,314	472	1,574	Upgrade
Market Cap Growth	140.00%	-68.55%	-10.67%	178.13%	-69.98%	28.51%	Upgrade
PS Ratio	-15.82	-5.20	106.70	6.35	2.78	-12.20	Upgrade
PB Ratio	2.39	0.50	0.65	0.51	0.17	0.52	Upgrade
P/FCF Ratio	7.64	24.61	-	6.92	1.82	9.60	Upgrade
P/OCF Ratio	7.70	21.71	-	6.14	1.50	8.79	Upgrade
Debt / Equity Ratio	3.32	3.09	1.51	1.14	1.07	0.95	Upgrade
Debt / FCF Ratio	10.59	153.40	-	15.38	11.62	17.51	Upgrade
Quick Ratio	1.87	0.26	0.56	0.49	0.73	1.49	Upgrade
Current Ratio	1.98	0.28	0.57	0.70	0.93	1.93	Upgrade
Asset Turnover	-	-	0.00	0.03	0.03	-	Upgrade
Return on Equity (ROE)	-51.44%	-79.55%	-36.87%	-7.70%	-20.41%	-12.63%	Upgrade
Return on Assets (ROA)	-16.94%	-25.33%	-14.59%	-3.31%	-9.59%	-6.21%	Upgrade
Return on Invested Capital (ROIC)	-19.21%	-7.64%	-4.46%	-1.59%	-2.32%	-8.67%	Upgrade
Earnings Yield	-42.00%	-242.49%	-39.36%	-20.09%	-78.32%	-23.89%	Upgrade
FCF Yield	13.10%	4.06%	-4.09%	14.46%	54.82%	10.42%	Upgrade
Buyback Yield / Dilution	-0.98%	1.06%	0.60%	1.63%	-6.06%	-21.39%	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.